All News

A New York pharmacist who heads up a nonprofit group is appealing for funds to computerize a pharmacy in Rwanda.

Tabula Rasa Strategies to offer medication therapy management consulting services.

A men's health group is organizing an online petition to urge Congress to rescind a CMS practice of restricting prostate cancer patients to the least costly drug alternative.

Covidien is recalling its heparin products supplied by Scientific Protein Laboratories because they contain a heparin-like contaminant.

CVS and National Council on Aging Extend Prescription for Better Health Partnership.

FDA warns consumers about recall of "Total Body Formula" and "Total Body Mega Formula".

FDA is looking at whether Ziagen and Videx is linked to more heart attacks.

Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.

FDA issues a notice requiring the manufacturers of 25 high-risk drugs and biologics to submit a REMS plan.

A work group is looking at what interoperatability standards are needed to establish electronic medication administration records in long-term care.

The FDA is undertaking a study of Merck?s Singulair to see if it is associated with a higher rate of suicide.

Schering-Plough has announced that FDA has approved a 1,400-mg dose of ribavirin and recommended that it be dosed based on patient weight.

The results of a demonstration project involving seven Bay Area hospitals showed that they cut their medication administration errors by 57% after they followed a set of six best practices.

Takeda survey results show pharmacists believe more patient information about insomnia medications is necessary.

A New Jersey pharmacist could be sentenced to three years of probation and a three-year suspension of his license for forging a prescription for oxycodone.

Prime Therapeutics introduces Triessent specialty pharmacy program

CIGNA adds online generic coupons and prescription drug price comparisons to its online prescription drug price quote tool

FDA warns consumers not to use Blue Steel and Hero products

The California Board of Pharmacy has announced that it will delay implementation of its electronic pedigree requirements until 2011.

FDA issues draft guidelines for drug-eluting stents

In a Federal Register notice, the Food & Drug Administration is seeking comments regarding prescription drug authentication

ClearScript looks to expand its medication therapy management program to employer health plans.

Medtronic recalls SynchroMed EL, SynchroMed II, and IsoMed implantable pumps

Scientific Protein Laboratories issues recall of heparin sodium active pharmaceutical ingredient

Rite Aid stores market Identigene's retail over-the-counter DNA paternity test kit

Another group, the Pharmaceutical Research & Manufacturers of America, is going green

Bryant Ranch Prepack prescription prepacker for physicians opens larger facility

Mifamurtide available through compassionate access study